A detailed history of Bank Of America Corp transactions in Incyte Corp stock. As of the latest transaction made, Bank Of America Corp holds 718,744 shares of INCY stock, worth $59.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
718,744
Previous 638,555 12.56%
Holding current value
$59.9 Million
Previous $36.4 Million 19.77%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $4.1 Million - $5.11 Million
80,189 Added 12.56%
718,744 $43.6 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $20 Million - $23.5 Million
352,868 Added 123.52%
638,555 $36.4 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $4.06 Million - $5 Million
-77,883 Reduced 21.42%
285,687 $17.9 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $20.2 Million - $25 Million
-331,476 Reduced 47.69%
363,570 $22.6 Million
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $22.8 Million - $28 Million
324,967 Added 87.81%
695,046 $50.2 Million
Q4 2022

Feb 10, 2023

BUY
$67.18 - $84.11 $4.91 Million - $6.14 Million
73,041 Added 24.59%
370,079 $29.7 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $6.67 Million - $8.35 Million
-100,826 Reduced 25.34%
297,038 $19.8 Million
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $2.01 Million - $2.52 Million
30,302 Added 8.24%
397,864 $0
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $7.49 Million - $9.04 Million
-113,463 Reduced 23.59%
367,562 $29.2 Million
Q4 2021

Feb 08, 2022

BUY
$63.34 - $74.11 $5.53 Million - $6.47 Million
87,365 Added 22.19%
481,025 $35.3 Million
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $494,080 - $604,523
-7,195 Reduced 1.79%
393,660 $27.1 Million
Q2 2021

Sep 13, 2021

BUY
$79.87 - $87.53 $32 Million - $35.1 Million
400,855 New
400,855 $33.7 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.